Assessment of Placental Disposition of Infliximab and Etanercept in Women With Autoimmune Diseases and in the Ex Vivo Perfused Placenta

Tumor necrosis factor (TNF) inhibitors are increasingly applied during pregnancy without clear knowledge of the impact on placenta and fetus. We assessed placental transfer and exposure to infliximab (n = 3) and etanercept (n = 3) in women with autoimmune diseases. Furthermore, we perfused healthy t...

Descripción completa

Detalles Bibliográficos
Autores principales: Eliesen, Gaby A. M., van Drongelen, Joris, van Hove, Hedwig, Kooijman, Nina I., van den Broek, Petra, de Vries, Annick, Roeleveld, Nel, Russel, Frans G. M., Greupink, Rick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325311/
https://www.ncbi.nlm.nih.gov/pubmed/32153014
http://dx.doi.org/10.1002/cpt.1827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325311/
https://www.ncbi.nlm.nih.gov/pubmed/32153014
http://dx.doi.org/10.1002/cpt.1827

Ejemplares similares